Down Over 60%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Unfortunately, shares of the healthcare stock have collapsed more than 60% from their previous peak. The stock had already been beaten down this year, but management recently incited another round of losses by announcing a new chief accountant and lowering its revenue guidance range. Are You Missing The Morning Scoop? Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Recent announcements might not bode well for TransMedics, but its proprietary organ care system (OCS) has been generating tremendous sales growth. In the first half of 2024, total revenue rocketed about 125% higher year over year. Let's look at what's gone wrong to see if this stock could be a bargain buy on the dip. On Dec. 2, TransMedics said the revenue guidance it had already lowered on Oct. 28 was no longer valid; management lowered the midpoint of its revenue guidance range to $430 million from $435 million. The difference was minor, but the stock fell hard The small guidance re
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferencePR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.MarketBeat
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
TMDX
Earnings
- 10/28/24 - Miss
TMDX
Sec Filings
- 12/11/24 - Form 4
- 12/9/24 - Form 8-K
- 12/6/24 - Form SCHEDULE
- TMDX's page on the SEC website